This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
28


nanotimes


Companies Facts


multiple adoptions in high volume manufacturing.” Furthermore, The Dow Chemical Company (NYSE: DOW) showcased its new solutions designed for photovoltaic manufacturers at this year’s 25th European Photovoltaic Solar Energy Conference and Exhibition (PVSEC) in Valencia, Spain (stand L3/H4/ B4, Hall 4, Feria Valencia). Dow’s photovoltaic solu- tions can help increase solar cell efficiency and solar module durability, improve device performance at lower cost, and enable widespread adoption of solar energy. Solutions being showcased include:


• Dow’s ENLIGHT™ cleaning, texturizing, imaging and metallization solutions to enhance perfor- mance in solar cell manufacturing,


• Dow’s ADCOTE™ and MOR-FREE™ adhesives for module fabrication for long-term durability with improved environmental profile,


• Dow’s new innovative ENLIGHT™ Polyolefin Encapsulant Films used as protective encapsulants help lower total module system costs and provide for improved productivity and extended reliability,


• DOWTHERM™ and SYLTHERM™ heat transfer fluid solutions for solar grade silicon production,


• Dow’s Polyglycol CF fluid for a higher quality experience in slicing silicon wafers.


http://www.photovoltaic-conference.com/ http://www.dow.com


E


MCORE Corporation (NASDAQ: EMKR) has received a Platinum Supplier Award from North-


rop Grumman Corporation (NYSE: NOC). EMCORE is a provider of compound semiconductor-based


components and subsystems for the fiber optic and solar power markets. http://www.emcore.com


O


n August 25, 2010, Emisphere Technologies, Inc. (OTCBB: EMIS) entered into a securities


purchase agreement with certain institutional inve- stors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28. Each unit, consisting of one share of common stock and a warrant to purchase 0.75 shares of common stock, will be sold at a purchase price of $1.01.


The warrants to purchase additional shares will be exercisable at an exercise price of $1.26 per share beginning immediately after issuance and will expire 5 years from the date they are first exercisable.


The Company also announced that, in connection with the above private placement, it has entered into a separate securities purchase agreement with MHR Fund Management LLC (together with its affiliates, „MHR“) pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28. Each unit, consisting of one share of common stock and a war- rant to purchase 0.75 shares of common stock, will be sold at a purchase price of $1.01. The warrants to purchase additional shares will be exercisable at an exercise price of $1.26 per share beginning immedi- ately after issuance and will expire 5 years from the date they are first exercisable. Emisphere is a bio-


10-09 :: September 2010


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81